Largest ever Parkinson’s research trial is starting now
Date
Research news
Date
We’ve awarded Pretzel Therapeutics £200,000 to investigate a new drug which could prevent cells from dying in Parkinson’s.
Date
In our latest round of grants we’ve awarded funding for new projects that aim to improve symptoms of Parkinson’s without the need for extra medication.
Date
The first participant has received either ambroxol or the placebo in the ASPro-PD trial. This marks the start of 330 people with Parkinson’s taking a component of an already approved drug over 2 years to see if it is beneficial.
Date
Parkinson’s UK and the UK Dementia Research Institute (UK DRI) join forces to establish a pioneering research centre.
Date
A study predicting health trends worldwide suggests that incidence of Parkinson’s is rising due to an ageing population.
Date
Nearly £600,000 has been awarded to 2 outstanding scientists to develop their Parkinson’s research careers.
Date
The full results show that exenatide had no benefits over the placebo and didn’t slow the progression of Parkinson’s.
Date
A small study of a drug called propranolol looked effective in easing tremor both at rest and in stressful situations for people with Parkinson’s.
Date
The TOP HAT trial was halted in April. We’re delighted to announce that it is restarting.